SCHEMBL280128

SCHEMBL280128

COC(=O)[C@]1(C)CCC[C@@]2(C)C(=O)CCCC21

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SOD1 P00441 1/20 0.54
CYP3A4 P08684 2/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
POLA1 P09884 4/20 0.49
ALDH1A1 P00352 1/20 0.45
ALOX15 P16050 1/20 0.45
NR1H2 P55055 3/20 0.44
NR1H3 Q13133 3/20 0.44
HSP90AA1 P07900 1/20 0.44
ABHD16A O95870 2/20 0.43
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279978 1.00 SOD1 (0.54) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL12704636 0.85 SOD1 (0.54) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL6008947 0.85 SOD1 (0.54) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL15604550 0.78 SOD1 (0.56) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL15603505 0.74 CYP3A4 (0.56) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL24711770 0.74 CYP3A4 (0.51) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL266913 0.74 CYP19A1 (0.44) CYP3A4MAPTMEN1KMT2AUSP2
SCHEMBL3146912 0.74 CYP19A1 (0.44) CYP3A4MAPTMEN1KMT2AUSP2
SCHEMBL15339315 0.73 SOD1 (0.73) SOD1CYP3A4MAPTMEN1KMT2A
SCHEMBL20561073 0.71 SOD1 (0.85) SOD1POLA1NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133915-B2 Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators NEREUS PHARMACEUTICALS, INC. (US) 2012-03-13 US disclosed
EP-2311795-A2 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators Nereus Pharmaceuticals, Inc. (US) 2011-04-20 EP disclosed
US-7342125-B2 Method of treating inflammation with acanthoic acid derivatives NEREUS PHARMACEUTICALS, INC. (US) 2008-03-11 US disclosed
US-7342125-B2 Method of treating inflammation with acanthoic acid derivatives NEREUS PHARMACEUTICALS, INC. (US) 2008-03-11 US disclosed